Details of the Drug Excipient
General Information of Drug Inactive Ingredient (DIG) (ID: E00370)
| DIG Name |
Sucralose
|
||||
|---|---|---|---|---|---|
| Synonyms |
Sucralose; 56038-13-2; Trichlorosucrose; Splenda; Aspasvit; Acucar Light; Trichlorogalacto-sucrose; 1',4,6'-Trichlorogalactosucrose; UNII-96K6UQ3ZD4; EINECS 259-952-2; BRN 3654410; 96K6UQ3ZD4; 1,6-Dichloro-1,6-dideoxy-beta-D-fructofuranosyl 4-chloro-4-deoxy-alpha-D-galactopyranoside; CHEBI:32159; 1,6-Dichloro-1,6-dideoxy-beta-D-fructofuranosyl-4-chloro-4-deoxy-alpha-D-galactopyranoside; (2R,3R,4R,5R,6R)-2-[(2R,3S,4S,5S)-2,5-bis(chloromethyl)-3,4-dihydroxyoxolan-2-yl]oxy-5-chloro-6-(hydroxymethyl)oxane-3,4-diol; CHEMBL3185084; DSSTox_CID_20245; DSSTox_RID_79457; DSSTox_GSID_40245; MFCD03648615; 4,1',6'-Trichloro-4,1',6'-trideoxy-galacto-sucrose; a-D-Galactopyranoside, 1,6-dichloro-1,6-dideoxy-b-D-fructofuranosyl4-chloro-4-deoxy-; (2R,3R,4R,5R,6R)-2-(((2R,3S,4S,5S)-2,5-Bis(chloromethyl)-3,4-dihydroxytetrahydrofuran-2-yl)oxy)-5-chloro-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4-diol; CAS-56038-13-2; Sucralose [BAN:NF]; 1,6-Dichloro-1,6-dideoxy-beta-D-fructofuranosyl 4-chloro-4-deoxy-alpha-D-galactose; E955; CCRIS 8449; Sucralose FCC; HSDB 7964; SCHEMBL3686; alpha-D-Galactopyranoside, 1,6-dichloro-1,6-dideoxy-beta-D-fructofuranosyl 4-chloro-4-deoxy-; Sucralose, analytical standard; DTXSID1040245; Sucralose 25% Liquid Concentrate; HMS2093H16; Pharmakon1600-01505953; (2R,3R,4R,5R,6R)-2-{[(2S,3R,4R,5R)-2,5-BIS(CHLOROMETHYL)-3,4-DIHYDROXYTETRAHYDROFURAN-2-YL]OXY}-5-CHLORO-6-(HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-3,4-DIOL; 40J; HY-N0614; Sucralose, >=98.0% (HPLC); ZINC4654665; Tox21_113658; Tox21_201752; Tox21_303425; BDBM50367128; NSC759272; s4214; AKOS015962432; CCG-213995; CS-8130; NSC-759272; NCGC00249110-01; NCGC00249110-03; NCGC00249110-04; NCGC00257400-01; NCGC00259301-01; (2R,3R,4R,5R,6R)-2-[(2R,3S,4S,5S)-2,5-bis(chloromethyl)-3,4-dihydroxy-tetrahydrofuran-2-yl]oxy-5-chloro-6-(hydroxymethyl)tetrahydropyran-3,4-diol; 1-(1,6-Dichloro-1,6-dideoxy-beta-D-fructofuranosyl)-4-chloro-4-deoxy-alpha-D-galactopyranoside; SBI-0206860.P001; Sucralose 1000 microg/mL in Acetonitrile; S0839; A22902; C12285; K-9960; AB01563242_01; AB01563242_02; 038S132; Q410209; SR-05000001935; SR-05000001935-1; W-203112; BRD-K58968598-001-03-6; Sucralose, European Pharmacopoeia (EP) Reference Standard; Sucralose, United States Pharmacopeia (USP) Reference Standard; Sucralose, Pharmaceutical Secondary Standard; Certified Reference Material; 1,6-Dichloro-1,6-dideoxy-beta-D-fructofuranosyl 4-chloro-4-deoxy-alpha-D-galactopyranoside; 1,6-dichloro-1,6-dideoxy-beta-d-fructofuranosyl4-chloro-4-deoxy-alpha-d-gala;; (2R,3R,4R,5R,6R)-2-((2R,3S,4S,5S)-2,5-bis(chloromethyl)-3,4-dihydroxytetrahydrofuran-2-yloxy)-5-chloro-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4-diol
|
||||
| DIG Function |
Flavoring agent
|
||||
| Formula |
C12H19Cl3O8
|
||||
| Canonical SMILES |
C([C@@H]1[C@@H]([C@@H]([C@H]([C@H](O1)O[C@]2([C@H]([C@@H]([C@H](O2)CCl)O)O)CCl)O)O)Cl)O
|
||||
| InChI |
1S/C12H19Cl3O8/c13-1-4-7(17)10(20)12(3-14,22-4)23-11-9(19)8(18)6(15)5(2-16)21-11/h4-11,16-20H,1-3H2/t4-,5-,6+,7-,8+,9-,10+,11-,12+/m1/s1
|
||||
| InChIKey |
BAQAVOSOZGMPRM-QBMZZYIRSA-N
|
||||
| Physicochemical Properties | Molecular Weight | 397.6 | Topological Polar Surface Area | 129 | |
| XlogP | -1.5 | Complexity | 405 | ||
| Heavy Atom Count | 23 | Rotatable Bond Count | 5 | ||
| Hydrogen Bond Donor Count | 5 | Hydrogen Bond Acceptor Count | 8 | ||
Full List of Drug(s) Co-administrated with This DIG